Profound Medical Corp. (PROF) Tops Q4 EPS by 72c

Profound Medical Corp. (NASDAQ: PROF) reported Q4 EPS of $0.42, $0.72 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $2 million versus the consensus estimate of $1.97 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c